ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $27.6M

      Shares

      258k

      % of Portfolio

      0.47%

      Average Buy Price

      $67.8

      Avg closing price
      Price range

      13 Jefferies Group Boston Scientific Trades

      Jefferies Group's position in Boston Scientific is currently worth $27.6M. That's 0.47% of their equity portfolio (51st largest holding). The first Boston Scientific trade was made in Q2 2018. Since then Jefferies Group bought shares six more times and sold shares on six occasions. The stake costed the investor $17.5M, netting the investor a gain of 58% so far.

      Avg closing price
      Price range
      Increased shares by 189.9% (+169k shares) Q2 2025
      Avg closing price $101.14
      Price range $89.70 - $107.41
      Sold 73.7% shares (-248k shares) Q1 2025
      Avg closing price $100.67
      Price range $89.38 - $106.18
      Sold 48.8% shares (-321k shares) Q4 2024
      Avg closing price $88.16
      Price range $83.62 - $91.51
      Sold 23.4% shares (-202k shares) Q3 2024
      Avg closing price $78.83
      Price range $72.96 - $84.00
      Increased shares by 304.6% (+648k shares) Q2 2024
      Avg closing price $73.20
      Price range $67.33 - $77.71
      Sold 54.3% shares (-252k shares) Q1 2024
      Avg closing price $64.30
      Price range $57.60 - $68.62
      Increased shares by 46.0% (+147k shares) Q4 2023
      Avg closing price $53.38
      Price range $48.64 - $57.81
      Sold 18.5% shares (-72.5k shares) Q3 2023
      Avg closing price $52.45
      Price range $50.19 - $54.68
      Increased shares by 112.1% (+207k shares) Q2 2023
      Avg closing price $52.23
      Price range $49.72 - $54.64
      Increased shares by 17727.7% (+183k shares) Q1 2023
      Avg closing price $47.13
      Price range $45.09 - $50.03
      New holding (+1.03k shares) Q4 2022
      Avg closing price $43.30
      Price range $39.56 - $47.20
      Sold -25k shares Q3 2018
      Avg closing price $34.93
      Price range $32.83 - $38.63
      New holding (+25k shares) Q2 2018
      Avg closing price $30.16
      Price range $26.84 - $34.32

      News about Boston Scientific Corp. and Jefferies Group

      Jefferies Financial Group Inc. Raises Stock Holdings in Boston Scientific Co. (NYSE:BSX)

      Jefferies Financial Group Inc. Raises Stock Holdings in Boston Scientific Co. (NYSE:BSX)

      Jefferies Financial Group Inc. boosted its holdings in Boston Scientific Co. (NYSE:BSX ¨C Free Report) by 124.3% in the second quarter, according to the compa...

      The AM Reporter The AM Reporter, almost 2 years ago
      3 Healthcare Stocks to Pick Up Before the Year-End Rally

      3 Healthcare Stocks to Pick Up Before the Year-End Rally

      With their robustness and growth potential, healthcare stocks are becoming a focal point in portfolios worldwide. Moreover, the U.S. stands out at the forefr...

      InvestorPlace InvestorPlace, almost 2 years ago
      Vigna Law Group: Boston Scientific¡¯s Marlex Mesh, is Being Called the Worst Polypropylene on the Market

      Vigna Law Group: Boston Scientific¡¯s Marlex Mesh, is Being Called the Worst Polypropylene on the Market

      Any physician that implants a Boston Scientific¡¯s marlex mid-urethral sling is exposed to big legal problems

      EIN News EIN News, over 2 years ago
      TISSIUM Appoints Sara Toyloy as Independent Board Member

      TISSIUM Appoints Sara Toyloy as Independent Board Member

      PARIS, FRANCE and BOSTON, MA / ACCESSWIRE / September 26, 2022 / TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for t...

      Accesswire Accesswire, almost 3 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×